Dudediligence.

Rocket Pharmaceuticals, Inc

RCKTNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

109.5M

on 2026-06-30, from 90.6M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

25M50M75M100MMar2024JunSepDec$12.50Mar2025JunSepDecMar2026Jun

Newest

$400.0M

S-3 of 2026-03-02. 1 prospectus supplement filed under it since. S-3 ↗

$100.0M

Cantor Fitzgerald, agreement of 2022-02-28. No at-the-market sales statement read from a 10-Q or 10-K. 8-K ↗

Warrants

5.50M

Warrants of every class as tagged in the XBRL facts on 2026-06-30. 10-Q ↗

Cash

6.7 quarters

$283.7M on 2026-06-30 ÷ $42.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2024-12-10Public offering13,200,000$12.50$165.0M424B5 ↗